The reverse side of the victory: Flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases

Author： Desar Ingrid   Mulder Sasja   Stillebroer Alexander   van Spronsen Dick-Johan   van der Graaf Winette   Mulders Peter   van Herpen Carla  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.48, Iss.6, 2009-08, pp. : 927-931

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flare up of symptoms after discontinuation of sunitinib in patient with lung cancer

By Guo Wanfeng   Liu Xiaoqing   Gao Hongjun  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 1133-1135

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib Therapy for Metastatic Renal Carcinoma in Patients with Low Cardiac Ejection Fraction: Report of Two Cases and Literature Review

By Kamada Pratima   Dudek Arkadiusz Z.  

Cancer Investigation, Vol. 28, Iss. 5, 2010-05 ,pp. : 501-504

Informa Healthcare

Access to resources Recommend Favorite

Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma

By Trask Peter  

Journal of Cancer Survivorship, Vol. 5, Iss. 3, 2011-09 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

Chromophobe renal cell carcinoma associated with eosinophilia: A report of three cases

By        

Experimental and Therapeutic Medicine, Vol. 8, Iss. 1, 2014-01 ,pp. : 91-94

Spandidos Publications

Access to resources Recommend Favorite

5fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma

By                    

Oncology Letters, Vol. 3, Iss. 6, 2012-01 ,pp. : 1195-1202

Spandidos Publications

Access to resources Recommend Favorite